# Resmonics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resmonics

- Industry: Medical Devices & Equipment
- Headquarters: Zurich, Switzerland
- Website: www.resmonics.ai
- Total disclosed funding: $0M
- Latest round: Seed (Nov 24, 2020)
- Investors on record: 1

## About

Resmonics AG focuses on delivering innovative solutions for infection prevention and hygiene management in healthcare settings through its advanced AI-driven technologies.Resmonics AG was founded in 2020 and is headquartered in Zurich, Switzerland. The company specializes in creating solutions that enhance hygiene compliance in healthcare environments. The founders, David Cleres, Matthias Groh, and Peter Tinschert, have prior entrepreneurial experiences. Resmonics has completed 2 deals, with the most recent deal occurring on January 19, 2021, where the company raised CHF 0.040 mn in a Seed funding round led by Venture Kick. The total amount raised by the company stands at CHF 0.040 mn.Resmonics AG specializes in advanced solutions for infection prevention and hygiene management within healthcare environments, primarily through its flagship product, Resmonics AI. This automated system leverages artificial intelligence and Internet of Things (IoT) technology to monitor hand and surface disinfectant usage in real-time, providing healthcare professionals with critical insights necessary for making informed decisions regarding patient and staff safety. The ResGuard Med software, certified as a medical device, detects and analyzes ambient respiratory symptoms to anticipate potential infection waves, thereby enabling proactive measures against healthcare-associated infections. The company targets hospitals and healthcare networks across various geographical markets including Europe and North America, aiming to enhance hygiene compliance and reduce the incidence of nosocomial infections. Resmonics’ clients include healthcare facilities that prioritize patient safety and seek to optimize their hygiene protocols based on objective, validated data.Resmonics AG generates revenue through a subscription-based model for its advanced hygiene monitoring solutions, allowing healthcare providers to access real-time data and insights tailored to their operational needs. Customers typically enter into service agreements that facilitate ongoing monitoring and support, thereby ensuring compliance with health standards and improving overall hygiene practices. The pricing structure is designed to meet the needs of mid-sized to large hospitals, focusing on the scalability of its solutions to accommodate varying operational sizes and complexities. This approach allows Resmonics to establish long-term partnerships with hospitals and healthcare networks, driving consistent revenue through direct engagements and subscription renewals for its proprietary AI-driven products.Resmonics AG plans to enhance its product offerings with new innovations designed to further aid infection prevention, although specific upcoming products and release dates were not disclosed. The company aims to expand its presence in both European and North American markets by the end of 2022. The recent Seed funding round, completed on January 19, 2021, will be utilized to support these expansion efforts and the development of new technologies to improve healthcare hygiene management.

## Funding rounds

- Seed, Nov 24, 2020, $0M — Venture Kick

## Investors

- Venture Kick (https://capitalatlas.ai/funds/venture-kick) — Seed